Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1254 clinical trials
featured
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease

  • 62 views
  • 08 Dec, 2020
  • 1 location
featured
Communication of Dementia Diagnoses: Investigating Patient, Family, and Physician Experiences and Developing Best Practices

This study involves a single interview of patients, caregivers, and health care professionals across Florida regarding their experiences in receiving and giving dementia diagnoses. The individual must live in Florida and have been diagnosed with dementia within the last 2 years to participate. Similarly, caregivers must live in Florida and …

  • 37 views
  • 23 Nov, 2020
  • 1 location
featured
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

  • 82 views
  • 25 Mar, 2021
  • 1 location
featured
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

  • 142 views
  • 08 Dec, 2020
  • 1 location
featured
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

  • 30 views
  • 25 Mar, 2021
  • 1 location
featured
Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury

Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury

  • 3822 views
  • 25 Mar, 2021
  • 1 location
featured
[Remote] Couples Lived Experience

assessment except for demographic questions, will be re-administered to each individual in the couple. At the end of each questionnaire battery, individuals will be screened for cognitive impairment and

  • 0 views
  • 19 May, 2021
  • 244 locations
Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients

days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non

  • 0 views
  • 25 Jan, 2021
  • 13 locations
Preventing Alzheimer's Disease With Cognitive Training

cognitive impairment is a transitional stage between normal cognitive aging and Alzheimer's disease or another type of dementia, and is indicative of higher risk for dementia. In addition to the obvious

  • 17 views
  • 18 Apr, 2021
  • 2 locations
A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma

followed by an infusion of Tositumomab (35 mg) that has been labeled with 5 mCi (0.18 GBq) of iodine 131. Whole body gamma camera scans will be obtained three times (Day 0, Day 2, 3, or 4, and

platelet count
tositumomab
rituxan
rituximab
measurable disease
  • 23 views
  • 07 Nov, 2020
  • 4 locations